Nanoliposomes for Controlled Release of Cannabinodiol at Relevant Gastrointestinal Conditions

[Image: see text] Cannabidiol (CBD) has significant therapeutic potential; nevertheless, its advance as an effective drug by the pharmaceutical business is hindered by its inherent characteristics, such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. This researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapata, Karol, Rosales, Stephania, Rios, As, Rojano, Benjamin, Toro-Mendoza, Jhoan, Riazi, Masoud, Franco, Camilo A., Cortés, Farid B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666248/
https://www.ncbi.nlm.nih.gov/pubmed/38027358
http://dx.doi.org/10.1021/acsomega.3c05371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666248/
https://www.ncbi.nlm.nih.gov/pubmed/38027358
http://dx.doi.org/10.1021/acsomega.3c05371

Ejemplares similares